Autoimmune Disease Therapeutics Market: Growth Forecast with a 3.5% CAGR from 2023 to 2030

Autoimmune Disease Therapeutics Market
Autoimmune thyroiditis, Hashimoto's disease. 3D illustration showing antibodies attacking thyroid gland

The global autoimmune disease therapeutics market is poised for substantial growth in the coming years, driven by increasing prevalence of autoimmune diseases and advancements in therapeutic interventions. According to recent market analysis, the market size was valued at USD 72.05 billion in 2022 and is expected to reach approximately USD 94.87 billion by 2030, growing at a remarkable compound annual growth rate (CAGR) of 3.5% during the forecast period of 2023-2030.

Key Players: Major key players in the autoimmune disease therapeutics market include:

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • UCB S.A.
  • Other prominent players

Market Analysis: The growth of the autoimmune disease therapeutics market is driven by several key factors, including:

  • Increasing Prevalence of Autoimmune Diseases: The rising incidence of autoimmune diseases globally is a major factor contributing to market growth.
  • Advancements in Therapeutic Interventions: Continuous advancements in biologics and targeted therapies are improving treatment outcomes and driving market expansion.
  • Rising Investments in Research and Development: Significant investments in R&D by pharmaceutical companies to develop novel treatments for autoimmune diseases are boosting market growth.

Get Free Sample Copy of Report:

Autoimmune Disease Therapeutics Marke


By Type of Disease:

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Psoriasis
  • Inflammatory Bowel Disease
  • Lupus
  • Others

By Drug Class:

  • Biologics
  • Disease-modifying Anti-rheumatic Drugs (DMARDs)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis: North America is expected to dominate the autoimmune disease therapeutics market throughout the forecast period, owing to the high prevalence of autoimmune diseases and favorable healthcare infrastructure. However, the Asia Pacific region is anticipated to witness the fastest growth rate, driven by increasing awareness, improving healthcare facilities, and rising patient population.

Key Takeaways:

  • The autoimmune disease therapeutics market is on track for substantial growth, driven by increasing disease prevalence and advancements in therapeutic options.
  • North America is expected to maintain market dominance, while Asia Pacific presents lucrative opportunities for market players.
  • Investments in R&D and the development of novel therapies are critical factors driving market expansion.

Get Free Sample Copy of Report: [Link]

Other Trending Reports:

Immunology Market Growth

Inflammatory Bowel Disease Drugs Market Growth

Injectable Cytotoxic Drugs Market Growth

Intraoral Cameras Market Growth

Ion Chromatography Market Growth

About Us: SNS Insider is a leading market research and consulting agency dominating the global market research industry. Our aim is to provide clients with the knowledge they need to navigate changing circumstances. To deliver current, accurate market data, consumer insights, and opinions, we utilize a variety of techniques including surveys, video talks, and focus groups globally.

Contact Us:

Akash Anand – Head of Business Development & Strategy


Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: SNS Insider